NIH-funded research NIH-funded research

Calmodulin changes that cause dangerous heart rhythms in CPVT

Official title: Multi-scale computational modeling of calmodulin mutations associated with CPVT

Funded at California State University Northridge · NIH-11323116 · Data updated 2026-11-12

Researchers are using computer models to link calmodulin gene changes to dangerous heart rhythms in people with CPVT.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionCalifornia State University Northridge
NIH-funded
Lab location1 site (Northridge, United States)
Project startMay 1, 2024
Project endApril 30, 2028
Funding year2026
Award (this year)$147,500
NIH project number5R16GM153647-03
Project IDNIH-11323116 on NIH RePORTER

Who could benefit from this research

Could help

People with CPVT or known calmodulin mutations (and their clinicians) are the most relevant audience for these findings.

Less likely to help

Patients whose arrhythmias are caused by other mechanisms, structural heart disease, or who lack calmodulin/RyR2 involvement may not benefit directly from this work.

What this research studies

This project will use detailed computer simulations to see how tiny changes in calmodulin affect its binding to the RyR2 calcium channel. The team runs molecular dynamics to model the molecular binding and then uses cell- and tissue-level electrical models to see how those molecular changes could trigger abnormal heartbeats. By connecting molecular, cellular, and tissue scales, the work aims to explain how a single genetic mutation can lead to life-threatening arrhythmias. The work is computational and does not involve direct patient procedures.

Why it matters

Potential benefit: If successful, the work could help identify which calmodulin mutations raise arrhythmia risk and guide future targeted treatments or monitoring for CPVT patients.

How similar studies have gone: Previous molecular and multi-scale cardiac models have advanced understanding of arrhythmias, but linking calmodulin-RyR2 mutations across scales to organ-level events is relatively novel.

Where this research is happening

  • California State University Northridge
    Northridge, United States
    Active

Researchers

  • Principal investigator: Shiferaw, Yohannes — California State University Northridge
  • Study coordinator: Shiferaw, Yohannes

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.